PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Certara, Princeton, NJ, USA.\', \'Division of Infectious Disease Pharmacology (DIDP), Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.\', \'Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/bcp.14859
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33855747
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
?:title
  • Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33855747>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33855747>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all